The Environmental Protection Agency (EPA) has approved Lysol Disinfectant Spray to combat SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).
The Environmental Protection Agency (EPA) has approved Lysol Disinfectant Spray to combat SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), based on the findings of a study published in the American Journal of Infection Control (AJIC), the agency announced in a press release.
As COVID-19 case counts climbed earlier this year, multiple sanitizers and disinfectants made claims of activity against the virus, but only EPA-approved products can legally market that way. With this week's approval, Lysol Disinfectant Spray (EPA Reg No. 777-99) and Lysol Disinfectant Max Cover Mist (EPA Reg No. 777-127) were found to inactivate the pathogen at 2 minutes of use on hard, non-porous surfaces, per EPA testing guidelines.
The AJIC peer-reviewed study evaluated the effectiveness of multiple products against SARS-CoV-2 and reported 99.9% efficacy for Lysol in particular.
Surface disinfection has been a key focus for investigators during the pandemic, as it wasn't initially clear just how long SARS-CoV-2 could live on various surfaces. Currently, the US Centers for Disease Control and Prevention (CDC) explains that "it may be possible that a person can get COVID-19 by touching a surface or object that has the virus on it and then touching their own mouth, nose, or possibly their eyes. This is not thought to be the main way the virus spreads, but we are still learning more about how this virus spreads."
The CDC recommends thorough disinfection using EPA-registered disinfectants on the agency's List N.
"The transmission of viral respiratory pathogens such as COVID-19 can be minimized by thorough and complete application of an EPA-registered disinfectant per the manufacturer’s instructions, that is included on EPA’s List N, to surfaces as well as good personal hygiene, including hand hygiene, minimize contact with your face, and respiratory hygiene/cough etiquette," William A. Rutala, PhD, MPH, CIC, and David J. Weber, MD, MPH, wrote in an article for Infection Control Today®.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.
Understanding NHSN's 2022 Rebaseline Data: Key Updates and Implications for HAI Reporting
December 13th 2024Discover how the NHSN 2022 Rebaseline initiative updates health care-associated infection metrics to align with modern health care trends, enabling improved infection prevention strategies and patient safety outcomes.
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Environmental Hygiene: Air Pressure and Ventilation: Negative vs Positive Pressure
December 10th 2024Learn more about how effective air pressure regulation in health care facilities is crucial for controlling airborne pathogens like tuberculosis and COVID-19, ensuring a safer environment for all patients and staff.
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.